Back to search

University of Thessaly (UTH)

Διερεύνηση του ρόλου της ενδοκάνης στις παροξύνσεις της χρόνιας αποφρακτικής πνευμονοπάθειας

Abstract

dc:description

Increasing evidence supports the presence of endothelial dysfunction in COPD, linking bronchial obstruction to the altered endothelial wall and encouraging the direction of research activity towards the description of relevant biomarkers that could improve our understanding of the disease's natural history. Endocan is a promising marker of endothelial dysfunction, preferentially expressed by the pulmonary endothelium, whose role in COPD has not yet been investigated.The present study aimed to investigate endocan’s levels in patients admitted for an acute exacerbation of COPD, in order to evaluate its potential in their assessment and to explore its role as a discriminator between various phenotypes. Thirty two patients admitted with an acute exacerbation of COPD were included in this study. The patients were followed up for one year post discharge and all new exacerbation episodes as well as disease related acute events were recorded. Endocan levels were determined on two separate occasions: on admission to the respiratory medicine department and after discharge, while in stable condition. In order to further assess its biomarker potential we concomitantly measured two well described inflammatory and endothelial dysfunction markers, CRP and vWF:Ag respectively.Serum endocan levels of stable COPD patients differed significantly according to the number of recorded exacerbations during follow up (P= 0.001). Significant differences in endocan levels were also observed according to the number of exacerbation related hospitalizations (P= 0.000). Furthermore, the absolute difference of its levels between exacerbated and stable COPD was the most significant predictor of the number of future exacerbations (P= 0.018, R2= 0.213), while the most significant predictor of endocan levels in stable COPD was the number of new exacerbation events during follow up (P= 0.001, R2= 0.351). Endocan levels did not change significantly between exacerbation and stable disease and showed no correlation with clinical parameters. Nevertheless, patients exhibiting the lowest serum endocan levels had a more favorable GOLD staging compared to the rest (P= 0.043). On the other hand, we observed significantly elevated vWF: Ag and CRP levels at exacerbation compared to stable COPD (Ρ= 0.003 and Ρ= 0.017) which also significantly differed among patients of various symptomatic severity, as assessed by the mMRC scale (P= 0.018 and P= 0.002).The results of the present study suggest that endocan may be a clinically relevant marker for COPD, potentially useful in the identification of patients prone to frequent exacerbations.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Maria, Kechagia
  • Κεχαγιά, Μαρία

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/44833

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Maria, Kechagia; Κεχαγιά, Μαρία. Διερεύνηση του ρόλου της ενδοκάνης στις παροξύνσεις της χρόνιας αποφρακτικής πνευμονοπάθειας. University of Thessaly (UTH), 2018. http://hdl.handle.net/10442/hedi/44833